TA may represent a minimally invasive therapeutic option for selected thyroid cancers beyond low-risk unifocal PTMC. Nevertheless, prospective studies with extended follow-up and direct comparative analyses with surgical management are required to better define its long-term oncologic role.
Xie et al. (2026) studied this question.